文献速递外周动脉疾病

透析患者孤立性胫动脉腔内治疗静息痛的结局

Outcomes of Isolated Tibial Endovascular Intervention for Rest Pain in Patients on Dialysis.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

回顾性分析2006至2016年829例因静息痛(Rutherford 4)行孤立性胫动脉腔内治疗的患者,其中171例透析、658例非透析。透析组5年临床有效率19±8%、无截肢生存率18±9%、免于主要不良肢体事件率21±8%,均显著低于非透析组(P<0.01),但30天结局相当。

要点

  • 透析患者静息痛行胫动脉腔内治疗短期结局与非透析相当。
  • 透析组5年临床有效率仅19±8%,远低于非透析组38±9%。
  • 透析组5年无截肢生存率18±9%,显著劣于非透析组45±8%。

核心结论

  • 透析的终末期肾病患者因静息痛行孤立性胫动脉腔内治疗,短期结局与非透析患者相当,但长期临床有效性和无截肢生存率不满意。

研究设计与样本

  • 回顾性查询2006至2016年下肢腔内治疗数据库,纳入静息痛(Rutherford 4)患者,排除跛行(Rutherford 1-3)和组织缺损(Rutherford 5-6)者。
  • 共829例患者(56%男性,平均年龄59岁;非透析658例,透析171例)接受单腿孤立性胫动脉干预。

主要发现

  • 技术成功率99%,中位每例治疗2根血管。
  • 透析组改良SVS流出道评分和足部流出道评分均更差。
  • 30天主要不良心脏事件和30天主要不良肢体事件两组相当。
  • 5年临床有效率非透析组38±9%、透析组19±8%(P<0.01)。
  • 5年无截肢生存率非透析组45±8%、透析组18±9%(P<0.01);5年免于主要不良肢体事件率分别为41±9%和21±8%(P<0.01)。

临床怎么用

  • 对透析合并静息痛患者行孤立性胫动脉腔内治疗前,应充分告知长期临床有效率和无截肢生存率较低。

局限性

  • 为单中心回顾性数据库研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tibial interventions for critical limb ischemia are frequent in patients with end-stage renal disease (ESRD) presenting with critical ischemia. The aim of this study was to examine impact of ESRD on the patient-centered outcomes following tibial endovascular Intervention for rest pain. METHODS: A database of patients undergoing lower extremity endovascular interventions between 2006 and 2016 was retrospectively queried. Patients with rest pain (Rutherford 4) were identified. Patients with claudication (Rutherford 1 to 3) and tissue loss (Rutherford 5 and 6) were excluded. Patients were categorized by the presence or absence of ESRD. Patient-orientated outcomes of clinical efficacy (CE; absence of recurrent symptoms, maintenance of ambulation, and absence of major amputation), amputation-free survival (AFS; survival without major amputation), and freedom from major adverse limb events (MALEs; above ankle amputation of the index limb or major reintervention new bypass graft, jump/interposition graft revision) were evaluated. RESULTS: A total of 829 patients (56% male, average age 59 years; 658 nonhemodialysis [non-HD] and 171 HD) underwent isolated tibial intervention in one leg for rest pain. Technical success was 99% with a median of 2 vessels treated per patient. There was no difference in the distribution of Trans-Atlantic Inter-Society Consensus I lesions, but both the modified Society for Vascular Surgery (SVS) runoff score and the pedal runoff score were worse in the HD group. The 30-day major adverse cardiac events and 30-day MALEs were equivalent in both groups. CE was 38 ± 9% and 19 ± 8% at 5 years for the non-HD and HD groups, respectively (P < 0.01). Overall, AFS was 45 ± 8% and 18 ± 9% at 5 years for the non-HD and HD groups, respectively (P < 0.01). Freedom from MALE was 41 ± 9% and 21 ± 8% at 5 years for the non-HD and HD groups, respectively (P < 0.01). CONCLUSIONS: Patients with ESRD who present with rest pain have equivalent short-term outcomes to those not on dialysis but do not achieve long-term satisfactory CE and AFS after isolated tibial intervention for rest pain.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Baer-Bositis HE, Hicks TD, Haidar GM, et al. Outcomes of Isolated Tibial Endovascular Intervention for Rest Pain in Patients on Dialysis. Ann Vasc Surg. 2017. PMID: 28479421. doi:10.1016/j.avsg.2017.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。